Taiwan's Medigen Vaccine Biologics Corp. (MVC) has applied to begin phase 2 testing of its COVID-19 vaccine, becoming the third local developer seeking permission to test the efficacy of its product on a larger scale, the company said Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
NIA busts illegal labor brokerage ring in Taichung, 33 sent to prosecutors
10/04/2025 04:33 PM - Politics
Taiwan says Lai has no overseas visit plan amid U.S. stopover attempt report
10/04/2025 04:09 PM - Sports
Taiwan's weightlifter bags women's bronze at world championships
10/04/2025 02:41 PM - Society
Taipei announces traffic controls for National Day
10/04/2025 02:28 PM - Society
Scorching heat, localized shower forecast in Taiwan on Saturday
10/04/2025 01:47 PM